Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-024696
Date:2021-04-01
Issuer: HORIZON THERAPEUTICS PUBLIC LTD CO (HZNP)
Original Submission Date:

Reporting Person:

CURTIS GEOFFREY M.
C/O HORIZON THERAPEUTICS PLC
CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD DUBLIN, L2 4

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
ORDINARY SHARES 2021-04-01 M 17,000 a $27.43 103,414 direct
ORDINARY SHARES 2021-04-01 M 20,000 a $29.22 123,414 direct
ORDINARY SHARES 2021-04-01 S 70,739 d $93.51 52,675 direct
ORDINARY SHARES 0 $0.00 420 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 27.43 2021-04-01 deemed execution date M 17,000 (d) 2025-04-08 ordinary shares 17,000 $27.43 0 direct
STOCK OPTION (RIGHT TO BUY) 29.22 2021-04-01 deemed execution date M 20,000 (d) 2025-05-01 ordinary shares 20,000 $29.22 0 direct
Footnotes
IDfootnote
f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 25, 2021.
f2 the reported price in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $93.51 to $93.57 per share, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
f3 the stock option is fully vested and exercisable.

Elevate your investments